UNIVERSAL HEALTH SERVICES INC
No SEC Form 4 filings for $UHS in the last 30 days.
See all $UHS insider activity →UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 d177070dex11.htm EX-1.1 EX-1.1 Exhibit 1.1 UNIVERSAL HEALTH SERVICES, INC. $600,000,000 5.500% Senior Secured Notes due 2031 $500,000,000 6.000% Senior Secured Notes due 2036 Underwriting Agreement August 11, 2026 J.P. Morgan Securities LLC BofA Securities, Inc. Truist S
S&P Global Ratings upgraded Universal Health Services (UHS) outlook to positive from stable and affirmed its BB+ issuer credit rating. S&P set a BBB- issue rating and a recovery rating of 2 for proposed senior notes. UHS plans to refinance a $700M 2026 note and fund part of its $835M Talkspace acquisition. S&P expects leverage to stay near 2.0x to 3.0x.
Simply Wall St says Universal Health Services (UHS) reported Q2 2026 revenue of $4,638.01 million and net income of $358.45 million. It also states UHS repurchased 1,890,000 shares for $320.3 million from Apr 1 to Jun 30, completing a roughly $6.62 billion buyback and reducing the share count. The piece cites analyst forecasts for 2029 revenue of about $20.7 billion and earnings of $1.5 billion.
Over the past 7 days, alphai's AI scored 3 news stories mentioning UHS (UNIVERSAL HEALTH SERVICES INC). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.
Recent UHS coverage spans earnings, corporate actions and financial news.
The filing discloses a new secured debt raise and stated use of proceeds to repay 2026 notes at maturity and revolver borrowings, shifting near-term funding and interest expense profile.
The positive outlook and leverage conditions create a near-term credit and refinancing narrative, potentially supporting spreads and equity sentiment.
Completed a large buyback and posted a Q2 beat, which can support per-share metrics, but the article flags Medicaid reimbursement risk as unchanged.
Guidance midpoint reductions despite revenue growth suggest margin/reimbursement uncertainty, likely pressuring near-term sentiment and valuation multiples.
The earnings call highlights a revenue beat but full-year EBITDA and EPS guidance that miss consensus, with volume growth moderated by care-setting shifts.
alphai scores every news story that mentions UHS with an AI model for sentiment and relevance, and aggregates insider trades from UNIVERSAL HEALTH SERVICES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 d177070dex11.htm EX-1.1 EX-1.1 Exhibit 1.1 UNIVERSAL HEALTH SERVICES, INC. $600,000,000 5.500% Senior Secured Notes due 2031 $500,000,000 6.000% Senior Secured Notes due 2036 Underwriting Agreement August 11, 2026 J.P. Morgan Securities LLC BofA Securities, Inc. Truist S
6 min readS&P Global Ratings upgraded Universal Health Services (UHS) outlook to positive from stable and affirmed its BB+ issuer credit rating. S&P set a BBB- issue rating and a recovery rating of 2 for proposed senior notes. UHS plans to refinance a $700M 2026 note and fund part of its $835M Talkspace acquisition. S&P expects leverage to stay near 2.0x to 3.0x.
4 min readSimply Wall St says Universal Health Services (UHS) reported Q2 2026 revenue of $4,638.01 million and net income of $358.45 million. It also states UHS repurchased 1,890,000 shares for $320.3 million from Apr 1 to Jun 30, completing a roughly $6.62 billion buyback and reducing the share count. The piece cites analyst forecasts for 2029 revenue of about $20.7 billion and earnings of $1.5 billion.
5 min readUniversal Health Services (UHS) reported Q2 revenue up 8.3% to $4.64B and net income attributable to UHS of $358.4M ($5.98/share). Despite growth, it cut the 2026 adjusted EPS and adjusted EBITDA outlook midpoints by 2.6% and 1.9%, citing changing Medicaid reimbursements and operating trends. It also reported first-half revenue up 8.9% to $9.13B.
4 min readUniversal Health Services reported Q2 2026 revenue of $4.64B, up 8.3% year over year and slightly above estimates ($4.59B). Adjusted EPS was $5.98, near expectations, while adjusted EBITDA was $684M. Full-year adjusted EPS guidance midpoint was $22.97, below estimates, and EBITDA guidance midpoint was $2.66B. Management discussed acute care volume moderation, bed ramp-up, Talkspace integration, and Medicaid supplemental payment uncertainty.
6 min readHospitals in the US report a rise in uninsured patients after enhanced ACA subsidies were not extended, according to The New York Times and Healthcare Dive. Universal Health Services (UHS) said losses from treating uninsured patients are higher than expected, and HCA Healthcare projected a $400 million revenue hit tied partly to more uninsured patients. SSM Health CEO cited patients unable to pay emergency bills.
6 min readGeorge Washington University’s Medical Faculty Associates (MFA) faces a stalled takeover as a jurisdiction dispute delays regulatory review. MFA, treating 4,600+ patients daily with over $400 million debt, would be acquired by Universal Health Services (UHS), with most doctors becoming UHS employees. D.C. AG Brian Schwalb ordered submission of documents by Sept. 30; parties dispute his authority.
6 min readUniversal Health Services (UHS) reported Q2 EPS of $5.98, above the $5.96 consensus, and sales of $4.638B, above $4.577B. The company cut FY2026 adjusted EPS guidance to $22.28-$23.65 from $22.64-$24.52. UHS shares rose 0.6% to $167.14. Analysts at Baird and Guggenheim lowered price targets after the results.
2 min readUBS lowered its price target for Universal Health Services to $290 from $310 while keeping a Buy rating, according to the note cited in the article. The stock was shown trading around $168.32 at publication.
1 min readMorgan Stanley lowered its Universal Health Services price target to $191 from $212 and kept an Equal Weight rating, according to the firm. The article cites the stock’s recent performance but provides no new company fundamentals or earnings figures.
1 min read
